C44H 48 N4O1V, triclinic, P¯ (no. 2), a = 9.0540(10) Å,
Atom Site x y z U iso H( ) i . . . . H( ) i − . . . . H( ) i . . . . H( ) i − . . . . H( ) i . . . . H( A) i . . . . H( B) i . . . . H( C) i . . . . H( ) i − . . . . H( ) i − . . . . H( ) i − . . . . H( A) i − . . . . H( B) i − . . . . H( C) i − . . . . H( A) i . . . . H( B) i . . . . H( C) i . . . . H( A) i . . . . H( B) i . . . . H( C) i . . . . H( A) i − . . . . H( B) i − . . . . H( C) i − . . . .
Atom Site
x y z U U U U U U C( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) V( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) N( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) N( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) O( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) N( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) N( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) C( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) C( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) − . ( ) C( ) i − . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) . ( ) C( ) i . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) − . ( ) − . ( ) . ( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ). ( ) − . ( ) . ( ) . ( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ) . ( ) .( ) − . ( ) . ( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ). ( ) − . ( ) − . ( ) . ( ) C( ) i .( ) . ( ) . ( ) . ( ) . ( ). ( ) − . ( ) − . ( ) . ( ) C( ) i − .( ) . ( ) . ( ) . ( ) . ( ). ( ) − . ( ) . ( ) . ( ) C( ) i − .( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( ) . ( )
Source of material
The tetra-azane ligand (LH 2 ) was synthesized according to the reported procedure [12] . The ligand LH 2 (641 mg, 1.00 mmol) was dissolved in the mixed solvent of THF (20 mL) at 195 K, then a solution of n-BuLi (2.00 M in hexane, 1.00 mL, 2.00 mmol) was added dropwise to a solution of LH 2 . The mixture was allowed to warm to room temperature and stirred for 1 h, and then a slurry of VOCl 2 (137.8 mg, 1.00 mmol) in THF (10 mL) was added. The solution was stirred at room temperature for 12 h. Then the volatiles were removed under reduced pressure and the residue was extracted into toluene. The product (Yield: 476 mg, 68.1%) was obtained as a purple powder after evaporating the solvent and washing with hexane. Dissolving the purple powder in CH 2 Cl 2 /hexane yielded a deep purple solution and after keeping the solution at 253 K for a period of three weeks, purple block-shaped crystals of the title compound were obtained.
Experimental details
All H atoms were placed in calculated positions and were included in the re nement in the riding model approximation, with U iso (H) set to 1.2Ueq(C). 
Discussion
Over recent years vanadium complexes carrying di erent tetradentate ligands have been extensively investigated.
Investigations into vanadium complexes are motivated by their wide range of properties useful for various applications, including pharmaceutics, catalysts and physiology [1] [2] [3] [4] [5] [6] . The title compound is a very important organic intermediate in the applications of medicines [7] . The title structure VL crystallized with one V(IV) atom, one oxygen atom and a L ligand molecule in the asymmetric unit. The V(IV) centre atom is tetragonal-pyramidal coordinated by four nitrogen atoms from L and one oxygen atom ( gure). The bond length between V1 and O1 (1.580(2) Å) is typical for ve-coordinate vanadyl species, which is found in other V = O containing complexe [8] . The o-phenylenediamine groups with the two amine nitrogen atoms (N3, N4) are bonded to the V atom with a distance of 2.015(3) Å and 2.016(3) Å, respectively, which are shorter than that of V1-N1 (2.122(2) Å) and V1-N2 (2.182(3) Å), and each of them is in the common range [9, 10] . The angles between N2-V1-N3 (85.75(10)°), and for N1-V1-N4 (82.09(10)°) are in accordance with the bite angles found for a similar vanadium complex with the tetradentate ligand [11] . In the structure, the angle N2-V1-N4 is 160.88(11)°, and the apical position is occupied by the oxygen atom. The N2-V1-N4 is divided into two similar angles through V = O, N2-CV1-CO1 of 94.09(11)°and N4-CV1-CO1 of 102.25(11)°. Accordingly the following angles are: N1-CV1-CN3 = 142.00(11)°, N3-CV1-CO1 = 112.85(12)°and N1-CV1-CO1 = 103.14(11)°.
